Peripheral Blood Occludin Level as a Biomarker for Perioperative Cerebral Edema in Patients with Brain Tumors

Figure 5

The relationship between the serum occludin level and the clinical outcomes in patients with brain tumors. (a) Comparison of National Institutes of Health Stroke Scale (NIHSS) and Glasgow Coma Scale (GCS) scores at admission between patients with a preoperative occludin () and those with a preoperative occludin (). (b) Comparison of the incidences of preoperative severe brain edema and intracranial hemorrhage between patients with a preoperative occludin () and those with a preoperative occludin (). (c) Comparison of NIHSS and GCS scores at 1 day after surgery between patients with a postoperative occludin () and those with a postoperative occludin (). (d) Comparison of the incidences of postoperative severe brain edema and intracranial hemorrhage between patients with a postoperative occludin () and those with a postoperative occludin ().

(a)

(b)

(c)

(d)